Page 121 - The clinical aspects and management of chronic migraine Judith Anne Pijpers
P. 121
References
1. Launer LJ, Terwindt GM, Ferrari MD. The prevalence and characteristics of migraine in a population- based cohort: The GEM Study. Neurology 1999;53(3):537–537.Available from: http://www. neurology.org/cgi/doi/10.1212/WNL.53.3.537
2. Headache Classification Committee of the International Headache Society. Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition. Cephalalgia 2018;38(1):1–211.Available from: http://journals.sagepub.com/ doi/10.1177/0333102417738202
3. May A, Schulte LH. Chronic migraine: risk factors, mechanisms and treatment. Nat. Rev. Neurol. 2016;12(8):455–464.Available from: http://www.nature.com/doifinder/10.1038/nrneurol.2016.93
4. Diener H-C, Dodick D, Evers S, et al. Pathophysiology, prevention, and treatment of medication overuse headache. Lancet Neurol. 2019;4422(19):1–12.Available from: https://linkinghub.elsevier. com/retrieve/pii/S1474442219301462
5. Chiang C-C, Schwedt TJ, Wang S-J, Dodick DW. Treatment of medication-overuse headache: A systematic review. Cephalalgia 2016;36(4):371–86.Available from: http://cep.sagepub.com/cgi/ doi/10.1177/0333102415593088
6. Goadsby PJ, Holland PR, Martins-oliveira M, et al. Pathophysiology of Migraine – A disorder of sensory processing. Physiol. Rev. 2017;97(2):553–622.
7. Burstein R, Yarnitsky D, Goor-Aryeh I, et al. An association between migraine and cutaneous allodynia. Ann. Neurol. 2000;47(5):614–624.
8. Burstein R, Jakubowski M, Garcia-Nicas E, et al. Thalamic sensitization transforms localized pain into widespread allodynia. Ann. Neurol. 2010;68(1):81–91.
9. Ferrari MD, Klever RR, Terwindt GM, et al. Migraine pathophysiology: lessons from mouse models and human genetics. Lancet Neurol. 2015;14(1):65–80.Available from: http://www.sciencedirect. com/science/article/pii/S1474442214702200
10. Louter MA, Bosker JE, van Oosterhout WPJ, et al. Cutaneous allodynia as a predictor of migraine chronification. Brain 2013;136(11):3489–3496.Available from: http://www.ncbi.nlm.nih.gov/ pubmed/24080152
11. Lipton RB, Bigal ME, Ashina S, et al. Cutaneous allodynia in the migraine population.. Ann. Neurol. 2008;63(2):148–58.Available from: http://www.pubmedcentral.nih.gov/articlerender. fcgi?artid=2729495&tool=pmcentrez&rendertype=abstract
12. Bigal, Ashina S, Burstein R, et al. Prevalence and characteristics of allodynia in headache sufferers: A population study. Neurology 2008;70(17):1525–1533.Available from: http://www.pubmedcentral. nih.gov/articlerender.fcgi?artid=2664547&tool=pmcentrez&rendertype=abstract
13. Jensen TS, Finnerup NB. Allodynia and hyperalgesia in neuropathic pain: Clinical manifestations and mechanisms. Lancet Neurol. 2014;13(9):924–935.Available from: http://dx.doi.org/10.1016/ S1474-4422(14)70102-4
14. Louter M, Wardenaar K, Veen G, et al. Allodynia is associated with a higher prevalence of depression in migraine patients. Cephalalgia 2014;34(14):1187–1192.Available from: http://www.ncbi.nlm.nih. gov/pubmed/24770422
15. Munksgaard SB, Bendtsen L, Jensen RH. Modulation of central sensitisation by detoxification in MOH: results of a 12-month detoxification study. Cephalalgia 2013;33(7):444–53.Available from: http://www.ncbi.nlm.nih.gov/pubmed/23431023
16. De Felice M, Ossipov MH, Wang R, et al. Triptan-induced latent sensitization a possible basis for medication overuse headache. Ann. Neurol. 2010;67(3):325–337.
17. Pijpers JA, Kies DA, Louter MA, et al. Acute withdrawal and botulinum toxin A in chronic migraine with medication overuse: a double-blind randomized controlled trial. Brain 2019;142(5):1203– 1214.Available from: https://academic.oup.com/brain/advance-article/doi/10.1093/brain/ awz052/5457721
18. Jakubowski M, Silberstein S, Ashkenazi A, Burstein R. Can allodynic migraine patients be identified interictally using a questionnaire? Neurology 2005;65(9):1419–22.Available from: http://www.ncbi. nlm.nih.gov/pubmed/16275830
19. Bjelland I, Dahl AA, Haug TT, Neckelmann D. The validity of the Hospital Anxiety and Depression Scale. J. Psychosom. Res. 2002;52(2):69–77.Available from: http://www.sciencedirect.com/science/ article/pii/S0022399901002963
6
Allodynia as predictor for treatment response
119